(Q80938331)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517230%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517230%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517230%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Grazia Malaponte

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517230%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Mario Falsaperla

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517230%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Massimo Madonia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517230%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Manuela Indelicato

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517230%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Salvatore Travali

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517230%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Maria Clorinda Mazzarino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517230%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

22 October 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517230%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517230%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517230%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517230%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

44-50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517230%20AND%20SRC:MED&resulttype=core&format=json

Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue

4 January 2020

cites work

1 reference

12 December 2020

A clinical update on chronic lymphocytic leukemia. I. Diagnosis and prognosis

1 reference

12 December 2020

Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma

1 reference

12 December 2020

Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resection

1 reference

12 December 2020

Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer

1 reference

12 December 2020

Serum metalloproteinases and their inhibitors: markers for malignant potential

1 reference

12 December 2020

Different mRNA and Protein Expression of Matrix Metalloproteinases 2 and 9 and Tissue Inhibitor of Metalloproteinases 1 in Benign and Malignant Prostate Tissue

1 reference

12 December 2020

Expression of matrix metalloproteinase-2 and prostate-specific antigen in localized and metastatic prostate cancer

1 reference

12 December 2020

Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer.

1 reference

12 December 2020

Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia

1 reference

12 December 2020

Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer

1 reference

12 December 2020

Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression.

1 reference

12 December 2020

Clinical use of prostate specific antigen in patients with prostate cancer

1 reference

12 December 2020

Increased expression of the 72-kd type IV collagenase in prostatic adenocarcinoma. Demonstration by immunohistochemistry and in situ hybridization

1 reference

12 December 2020

Increased incidence of matrix metalloproteinases in urine of cancer patients

1 reference

12 December 2020

In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer

1 reference

12 December 2020

mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue

1 reference

12 December 2020

Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2.

1 reference

12 December 2020

Metastatic potential correlates with enzymatic degradation of basement membrane collagen

1 reference

12 December 2020

An overview of collagenase-3 expression in malignant tumors and analysis of its potential value as a target in antitumor therapies.

1 reference

12 December 2020

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

1 reference

12 December 2020

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

12 December 2020

Expression of tissue inhibitor of metalloproteinase-1 and type IV collagenase/gelatinase messenger RNAs in human breast cancer.

1 reference

12 December 2020

10.1007/S00240-004-0440-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15517230%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference